Co-Infection of the Epstein-Barr Virus and the Kaposi Sarcoma-Associated Herpesvirus.

B cell lymphomas Kaposi sarcoma T cells cytotoxic lymphocytes humanized mice latent and lytic infection natural killer cells

Journal

Viruses
ISSN: 1999-4915
Titre abrégé: Viruses
Pays: Switzerland
ID NLM: 101509722

Informations de publication

Date de publication:
02 12 2022
Historique:
received: 31 10 2022
revised: 28 11 2022
accepted: 30 11 2022
entrez: 23 12 2022
pubmed: 24 12 2022
medline: 27 12 2022
Statut: epublish

Résumé

The two human tumor viruses, Epstein-Barr virus (EBV) and Kaposi sarcoma-associated herpesvirus (KSHV), have been mostly studied in isolation. Recent studies suggest that co-infection with both viruses as observed in one of their associated malignancies, namely primary effusion lymphoma (PEL), might also be required for KSHV persistence. In this review, we discuss how EBV and KSHV might support each other for persistence and lymphomagenesis. Moreover, we summarize what is known about their innate and adaptive immune control which both seem to be required to ensure asymptomatic persistent co-infection with these two human tumor viruses. A better understanding of this immune control might allow us to prepare for vaccination against EBV and KSHV in the future.

Identifiants

pubmed: 36560713
pii: v14122709
doi: 10.3390/v14122709
pmc: PMC9782805
pii:
doi:

Types de publication

Journal Article Review Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Références

PLoS One. 2009 Jun 17;4(6):e5890
pubmed: 19536280
Science. 1999 Apr 23;284(5414):641-4
pubmed: 10213686
Antiviral Res. 2007 Jan;73(1):12-23
pubmed: 16842866
Blood. 2015 May 14;125(20):e14-22
pubmed: 25827832
PLoS Pathog. 2015 Dec 01;11(12):e1005286
pubmed: 26624012
Vaccine. 2019 Jul 9;37(30):4184-4194
pubmed: 31201053
J Virol. 2012 Nov;86(21):11663-74
pubmed: 22896623
Curr Opin Virol. 2022 Feb;52:39-47
pubmed: 34872030
Blood. 2022 Feb 17;139(7):1013-1025
pubmed: 34479367
Blood Cancer J. 2016 Feb 26;6:e398
pubmed: 26918362
J Immunol. 2013 Dec 1;191(11):5398-409
pubmed: 24146041
Semin Cancer Biol. 2015 Oct;34:52-7
pubmed: 26118690
Clin Immunol. 2015 Dec;161(2):131-5
pubmed: 26307434
Curr Opin Oncol. 2022 Sep 1;34(5):432-438
pubmed: 35838208
J Clin Invest. 2018 Jun 1;128(6):2519-2534
pubmed: 29733294
Nat Commun. 2020 Jul 31;11(1):3849
pubmed: 32737300
J Exp Med. 2000 May 15;191(10):1649-60
pubmed: 10811859
Blood. 2005 May 15;105(10):3987-94
pubmed: 15665117
Proc Natl Acad Sci U S A. 2004 Jan 6;101(1):141-6
pubmed: 14691250
J Infect Dis. 2005 Nov 1;192(9):1513-24
pubmed: 16206065
J Infect Dis. 2015 Jun 1;211(11):1842-51
pubmed: 25492914
Blood. 1996 Jul 15;88(2):645-56
pubmed: 8695812
Immunity. 1998 Sep;9(3):395-404
pubmed: 9768759
PLoS Pathog. 2021 Aug 20;17(8):e1009868
pubmed: 34415956
Cell Rep. 2020 Oct 13;33(2):108249
pubmed: 33053346
Philos Trans R Soc Lond B Biol Sci. 2019 May 27;374(1773):20180296
pubmed: 30955487
PLoS Pathog. 2014 Aug 28;10(8):e1004333
pubmed: 25165855
Blood. 2009 May 28;113(22):5660-8
pubmed: 19324905
J Virol. 2004 Jan;78(2):768-78
pubmed: 14694109
Annu Rev Pathol. 2014;9:349-72
pubmed: 24111911
Front Immunol. 2020 Jun 17;11:1231
pubmed: 32625211
Virology. 2001 Aug 15;287(1):62-70
pubmed: 11504542
J Virol. 2001 Apr;75(7):3250-8
pubmed: 11238851
Medicine (Baltimore). 2021 Dec 23;100(51):e28328
pubmed: 34941134
J Virol. 2003 Feb;77(4):2631-9
pubmed: 12552002
J Immunol. 2001 Oct 15;167(8):4450-7
pubmed: 11591771
Curr Top Microbiol Immunol. 2015;391:265-87
pubmed: 26428378
Blood Rev. 2018 May;32(3):203-224
pubmed: 29198753
Eur J Immunol. 2005 Oct;35(10):2956-61
pubmed: 16134085
J Biol Chem. 2010 Mar 5;285(10):7208-21
pubmed: 20048166
J Immunol. 2002 Apr 15;168(8):4184-91
pubmed: 11937579
J Virol. 2015 Feb;89(3):1731-43
pubmed: 25410866
PLoS Pathog. 2018 Sep 24;14(9):e1007110
pubmed: 30248160
J Infect Dis. 2013 Jan 1;207(1):80-8
pubmed: 23100562
PLoS One. 2021 Jul 2;16(7):e0254177
pubmed: 34214127
Oncogene. 2004 Jan 15;23(2):514-23
pubmed: 14724579
Immunol Rev. 2019 Sep;291(1):174-189
pubmed: 31402499
Front Oncol. 2019 Aug 06;9:713
pubmed: 31448229
Blood. 1997 Aug 1;90(3):1186-91
pubmed: 9242551
Nat Rev Microbiol. 2019 Nov;17(11):691-700
pubmed: 31477887
Proc Natl Acad Sci U S A. 2018 Nov 27;115(48):E11379-E11387
pubmed: 30429324
J Virol. 2011 Jan;85(1):165-77
pubmed: 20980506
Science. 2022 Jan 21;375(6578):296-301
pubmed: 35025605
Immunity. 2000 Oct;13(4):497-506
pubmed: 11070168
PLoS Pathog. 2021 Jan 7;17(1):e1009091
pubmed: 33411730
Cancer Res. 2008 Sep 1;68(17):6963-8
pubmed: 18757410
J Immunol. 2019 Sep 1;203(5):1276-1287
pubmed: 31308093
J Infect Dis. 2007 Dec 15;196(12):1749-53
pubmed: 18190254
J Natl Cancer Inst. 2002 Jun 19;94(12):926-35
pubmed: 12072546
Sci Rep. 2017 Sep 5;7(1):10479
pubmed: 28874674
J Virol. 2007 Sep;81(18):9825-37
pubmed: 17626102
FASEB J. 2019 Sep;33(9):10563-10576
pubmed: 31337264
Front Cell Infect Microbiol. 2021 Mar 26;11:605258
pubmed: 33842383
J Exp Med. 2005 Feb 7;201(3):349-60
pubmed: 15684323
J Innate Immun. 2017;9(6):574-586
pubmed: 28877527
Viruses. 2014 Sep 19;6(9):3472-86
pubmed: 25243371
Genes Immun. 2012 Jan;13(1):14-20
pubmed: 21776012
J Exp Med. 2002 Apr 1;195(7):893-905
pubmed: 11927633
J Mol Biol. 2022 Mar 30;434(6):167214
pubmed: 34437888
PLoS Pathog. 2018 Apr 30;14(4):e1007039
pubmed: 29709016
Proc Natl Acad Sci U S A. 2008 Feb 5;105(5):1656-61
pubmed: 18230726
J Interferon Cytokine Res. 2011 Nov;31(11):791-801
pubmed: 21767154
Cell Host Microbe. 2017 Jul 12;22(1):61-73.e7
pubmed: 28704654
Blood. 2000 Oct 1;96(7):2537-42
pubmed: 11001908
Annu Rev Immunol. 2011;29:447-91
pubmed: 21219179
Cancers (Basel). 2022 Aug 25;14(17):
pubmed: 36077655
PLoS Pathog. 2013 Aug;9(8):e1003568
pubmed: 23966863
Annu Rev Genomics Hum Genet. 2013;14:215-43
pubmed: 23724903
J Exp Med. 2013 May 6;210(5):933-49
pubmed: 23569328
Cell Rep. 2021 May 4;35(5):109056
pubmed: 33951431
J Virol. 2005 Nov;79(22):13993-4003
pubmed: 16254335
J Exp Med. 1998 May 4;187(9):1395-402
pubmed: 9565632
J Virol. 2013 Apr;87(7):4060-70
pubmed: 23365429
Blood. 2006 Dec 1;108(12):3871-80
pubmed: 16926293
J Gen Virol. 2010 Mar;91(Pt 3):622-9
pubmed: 19923262
N Engl J Med. 2003 Oct 2;349(14):1324-32
pubmed: 14523140
J Hum Virol. 1999 Jan-Feb;2(1):38-44
pubmed: 10200598
J Virol. 2000 Oct;74(20):9637-45
pubmed: 11000236
Curr Top Microbiol Immunol. 2015;391:237-61
pubmed: 26428377
Haematologica. 2019 Mar;104(3):564-575
pubmed: 30309853
J Immunol. 2012 Oct 15;189(8):3795-9
pubmed: 22984081
Blood. 2008 Feb 1;111(3):1387-95
pubmed: 18000163
Proc Natl Acad Sci U S A. 2019 Aug 13;116(33):16519-16528
pubmed: 31363046
Nat Microbiol. 2019 Mar;4(3):404-413
pubmed: 30664667
Blood Adv. 2019 Apr 9;3(7):1129-1144
pubmed: 30952679
J Immunol. 2008 Mar 1;180(5):3417-25
pubmed: 18292568
J Leukoc Biol. 2017 Nov;102(5):1199-1217
pubmed: 28848041
J Immunol. 2017 May 15;198(10):4062-4073
pubmed: 28416598
PLoS Pathog. 2015 Mar 27;11(3):e1004746
pubmed: 25816224
J Exp Med. 1996 May 1;183(5):2385-90
pubmed: 8642350
J Biol Chem. 2003 Feb 7;278(6):3694-704
pubmed: 12446712
Nat Rev Dis Primers. 2019 Jan 31;5(1):9
pubmed: 30705286
Int J Cancer. 2007 Sep 15;121(6):1274-81
pubmed: 17520680
Blood. 2012 May 31;119(22):5173-81
pubmed: 22490805
J Clin Invest. 2016 Sep 1;126(9):3165-75
pubmed: 27584730
J Gen Virol. 1998 Jun;79 ( Pt 6):1445-52
pubmed: 9634087
J Immunol. 2001 Jul 1;167(1):505-13
pubmed: 11418689
J Virol. 2007 Jan;81(2):474-82
pubmed: 17079298
Blood. 2005 Mar 15;105(6):2510-8
pubmed: 15572586
J Infect Dis. 2015 Dec 15;212(12):1957-61
pubmed: 26080368
Front Immunol. 2020 Feb 07;10:3084
pubmed: 32117196
J Virol. 2014 Aug;88(16):9335-49
pubmed: 24899205
J Immunol. 2000 Aug 15;165(4):2077-83
pubmed: 10925292
Oncotarget. 2016 Nov 8;7(45):72961-72977
pubmed: 27662664
J Virol. 2001 Oct;75(19):9446-57
pubmed: 11533207
J Virol. 2015 Nov 04;90(2):947-58
pubmed: 26537677
Oncogene. 1999 Oct 14;18(42):5738-46
pubmed: 10523854
J Virol. 2013 Jul;87(14):8179-94
pubmed: 23698302
J Cancer Res Clin Oncol. 2022 Jan;148(1):31-46
pubmed: 34705104
J Virol. 2005 Jan;79(2):1296-307
pubmed: 15613356
J Biol Chem. 2011 Jan 7;286(1):746-56
pubmed: 20980251
NPJ Vaccines. 2022 Sep 20;7(1):108
pubmed: 36127367
Eur J Cancer. 2001 Jul;37(10):1251-69
pubmed: 11423257
Leuk Res. 2004 Apr;28(4):333-8
pubmed: 15109530
PLoS Pathog. 2018 Jul 27;14(7):e1007179
pubmed: 30052684
PLoS One. 2008 Feb 06;3(2):e1569
pubmed: 18253508
J Virol. 2007 Oct;81(20):10950-60
pubmed: 17652396
PLoS Pathog. 2012 Jan;8(1):e1002486
pubmed: 22253598
N Engl J Med. 1995 May 4;332(18):1186-91
pubmed: 7700311
Oncotarget. 2017 Nov 25;8(65):109402-109416
pubmed: 29312617
J Gen Virol. 2003 Apr;84(Pt 4):965-974
pubmed: 12655098
Curr Opin Virol. 2018 Oct;32:60-70
pubmed: 30268927
Front Immunol. 2019 Sep 18;10:2193
pubmed: 31620125
FEMS Microbiol Rev. 2019 Mar 1;43(2):181-192
pubmed: 30649299
Proc Natl Acad Sci U S A. 2004 Jan 6;101(1):239-44
pubmed: 14688409
Curr Opin Virol. 2015 Oct;14:116-28
pubmed: 26431609
J Immunol. 2011 Feb 1;186(3):1694-702
pubmed: 21191071
Expert Rev Hematol. 2017 Jun;10(6):505-514
pubmed: 28468596
J Clin Invest. 2019 May 1;129(5):2071-2087
pubmed: 31042161
J Virol. 2011 Dec;85(23):12821-4
pubmed: 21917961
Cancer Res. 2004 Apr 15;64(8):2774-81
pubmed: 15087393
Sci Transl Med. 2022 May 4;14(643):eabf3685
pubmed: 35507671
Virology. 1999 Sep 15;262(1):18-30
pubmed: 10489337
J Pediatr. 2004 Apr;144(4):519-23
pubmed: 15069403
Oncotarget. 2017 May 23;8(21):34481-34497
pubmed: 28404899
Proc Natl Acad Sci U S A. 2002 Apr 16;99(8):5573-8
pubmed: 11943871
Nat Commun. 2021 Dec 16;12(1):7323
pubmed: 34916520
Clin Lymphoma Myeloma Leuk. 2022 Jul;22(7):e485-e494
pubmed: 35110006
Viruses. 2021 Jul 28;13(8):
pubmed: 34452344
J Virol. 2009 Feb;83(4):1856-69
pubmed: 19052084
Clin Infect Dis. 2006 Aug 1;43(3):276-82
pubmed: 16804839
PLoS Pathog. 2012;8(5):e1002704
pubmed: 22615564
Sci Transl Med. 2011 Nov 2;3(107):107fs7
pubmed: 22049067
J Virol. 2006 Mar;80(5):2257-66
pubmed: 16474133
J Virol. 2007 Jun;81(11):6068-78
pubmed: 17376914
Curr Top Microbiol Immunol. 2015;391:61-117
pubmed: 26428372
Cancer Res. 2013 Mar 15;73(6):1676-88
pubmed: 23348421
Int J Cancer. 2019 Nov 1;145(9):2468-2477
pubmed: 31265124
J Virol. 2010 Oct;84(20):10488-500
pubmed: 20686042
J Virol. 2019 Jun 14;93(13):
pubmed: 30971472
Cell Rep. 2013 Dec 26;5(6):1489-98
pubmed: 24360958
Semin Immunol. 2022 Mar;60:101652
pubmed: 36162228
Science. 2011 Jan 21;331(6015):330-4
pubmed: 21252346
Oral Dis. 2016 Apr;22 Suppl 1:120-7
pubmed: 27109280
Cancers (Basel). 2020 Jun 05;12(6):
pubmed: 32517128
J Virol. 1998 Jun;72(6):5182-8
pubmed: 9573290
Curr Opin Virol. 2021 Feb;46:1-8
pubmed: 32771660
J Clin Virol. 2018 May;102:84-92
pubmed: 29525635
Blood. 2008 Jan 1;111(1):320-7
pubmed: 17890449
JAMA. 2002 Mar 13;287(10):1295-300
pubmed: 11886321
Blood. 1999 Oct 15;94(8):2871-9
pubmed: 10515891
Immunity. 2005 Jan;22(1):59-70
pubmed: 15664159
Virology. 2014 Jan 5;448:293-302
pubmed: 24314660
Lancet Glob Health. 2020 Feb;8(2):e180-e190
pubmed: 31862245
PLoS One. 2019 Dec 17;14(12):e0226436
pubmed: 31846480
Onco Targets Ther. 2018 Jun 28;11:3747-3754
pubmed: 29988764
Vaccine. 2007 Jun 11;25(24):4697-705
pubmed: 17485150
Br J Haematol. 2005 Apr;129(2):266-74
pubmed: 15813855
Clin Cancer Res. 2014 Oct 1;20(19):5009-22
pubmed: 25124688
Pediatr Infect Dis J. 2004 Jul;23(7):671-4
pubmed: 15247609
J Virol. 2011 Dec;85(24):13105-13
pubmed: 21994444
Cell Host Microbe. 2010 Dec 16;8(6):510-22
pubmed: 21147465
Blood. 2006 Apr 15;107(8):3295-302
pubmed: 16380446
J Infect Dis. 2006 Oct 15;194(8):1078-88
pubmed: 16991082
Cancer Cell. 2003 Jan;3(1):23-36
pubmed: 12559173
J Virol. 2013 Sep;87(17):9398-410
pubmed: 23785197
Blood. 2001 Apr 15;97(8):2366-73
pubmed: 11290599
Cell Host Microbe. 2017 Jul 12;22(1):5-7
pubmed: 28704653
Curr Opin Virol. 2011 Dec;1(6):487-96
pubmed: 22347990
Science. 2002 Nov 15;298(5597):1432-5
pubmed: 12434062
Eur J Immunol. 2001 Apr;31(4):1217-20
pubmed: 11298347
Nat Med. 2003 Mar;9(3):307-14
pubmed: 12592401
Mol Cancer. 2010 Jan 05;9:1
pubmed: 20051109
Blood. 2014 Oct 16;124(16):2533-43
pubmed: 25205117
Adv Virol. 2010;2010:340356
pubmed: 22331985
Exp Gerontol. 2007 Jun;42(6):563-70
pubmed: 17337145
Clin Vaccine Immunol. 2010 Oct;17(10):1507-16
pubmed: 20719985
PLoS Pathog. 2018 Feb 20;14(2):e1006890
pubmed: 29462212
Nat Rev Immunol. 2022 Dec;22(12):734-750
pubmed: 35508809
Cancer Res. 2005 Mar 1;65(5):1738-47
pubmed: 15753369
J Exp Med. 2007 Aug 6;204(8):1863-73
pubmed: 17620360
AIDS. 2009 Sep 10;23(14):1918-22
pubmed: 19609199
Virology. 2020 Feb;541:160-173
pubmed: 32056714
Nat Immunol. 2010 Nov;11(11):975-8
pubmed: 20959798
Annu Rev Pathol. 2019 Jan 24;14:29-53
pubmed: 30125149
Haematologica. 2015 Nov;100(11):e467-70
pubmed: 26206802
Ann Neurol. 2006 Mar;59(3):499-503
pubmed: 16502434
Cell Host Microbe. 2009 Apr 23;5(4):376-85
pubmed: 19380116
Elife. 2019 Apr 16;8:
pubmed: 30990165
mBio. 2020 Aug 25;11(4):
pubmed: 32843547
EMBO J. 1996 Dec 16;15(24):7070-8
pubmed: 9003782
J Virol. 2005 Oct;79(19):12173-84
pubmed: 16160144

Auteurs

Michelle Böni (M)

Viral Immunobiology, Institute of Experimental Immunology, University of Zürich, 8057 Zurich, Switzerland.

Lisa Rieble (L)

Viral Immunobiology, Institute of Experimental Immunology, University of Zürich, 8057 Zurich, Switzerland.

Christian Münz (C)

Viral Immunobiology, Institute of Experimental Immunology, University of Zürich, 8057 Zurich, Switzerland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH